Generic Pharmaceuticals Contract Manufacturing Market Size, Share & Trends Analysis Report By Drug Type (Branded, Unbranded), By Product (API, Drug Product), By Route Of Administration, By Application, And Segment Forecasts, 2022 - 2030

1.1. Market Segmentation & Scope
1.1.1. Drug Type
1.1.2. Product
1.1.3. Route of Administration
1.1.4. Application
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

2.1. Market Outlook

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Supportive government initiatives to improve the adoption of generic drugs
3.3.1.2. Significant number of drugs losing patents
3.3.1.3. Growing prevalence of chronic diseases contributing to the demand for cost-effective generics
3.3.2. Market restraint analysis
3.3.2.1. Third party performance
3.4. Generic pharmaceuticals contract manufacturing market Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.4.2. PESTLE Analysis
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.3.1. Mergers and Acquisition
3.4.3.2. Expansions
3.4.3.3. Agreements and Collaborations
3.4.3.4. Product and Service Launches
3.5. Covid-19 Impact and Reformation Strategy

4.1. Definitions and Scope
4.2. Generic pharmaceuticals contract manufacturing market Share, 2021 & 2030
4.2.1. Branded Generics
4.2.1.1. Branded Generics market estimates and forecast 2018 to 2030 (USD Billion)
4.2.2. Unbranded Generics
4.2.2.1. Unbranded market estimates and forecast 2018 to 2030 (USD Billion)

5.1. Definitions and Scope
5.2. Generic pharmaceuticals contract manufacturing market Share, 2021 & 2030
5.2.1. API
5.2.1.1. API market estimates and forecast 2018 to 2030 (USD Billion)
5.2.2. Drug Product
5.2.2.1. Drug Product market estimates and forecast 2018 to 2030 (USD Billion)

6.1. Definitions and Scope
6.2. Generic pharmaceuticals contract manufacturing market Share, 2021 & 2030
6.2.1. Oral
6.2.1.1. Oral market estimates and forecast 2018 to 2030 (USD Billion)
6.2.2. Parenteral
6.2.2.1. Parenteral market estimates and forecast 2018 to 2030 (USD Billion)
6.2.3. Topical
6.2.3.1. Topical g market estimates and forecast 2018 to 2030 (USD Billion)
6.2.4. Others
6.2.4.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

7.1. Definitions and Scope
7.2. Generic pharmaceuticals contract manufacturing market Share, 2021 & 2030
7.2.1. Oncology
7.2.1.1. Oncology market estimates and forecast 2018 to 2030 (USD Billion)
7.2.2. Immunology
7.2.2.1. Immunology market estimates and forecast 2018 to 2030 (USD Billion)
7.2.3. Antidiabetic
7.2.3.1. Antidiabetic market estimates and forecast 2018 to 2030 (USD Billion)
7.2.4. Neurology
7.2.4.1. Neurology market estimates and forecast 2018 to 2030 (USD Billion)
7.2.5. Anticoagulants
7.2.5.1. Anticoagulants market estimates and forecast 2018 to 2030 (USD Billion)
7.2.6. Cardiovascular
7.2.6.1. Cardiovascular market estimates and forecast 2018 to 2030 (USD Billion)
7.2.7. Respiratory
7.2.7.1. Respiratory market estimates and forecast 2018 to 2030 (USD Billion)
7.2.8. Pain
7.2.8.1. Pain market estimates and forecast 2018 to 2030 (USD Billion)
7.2.9. HIV Antivirals
7.2.9.1. HIV antivirals market estimates and forecast 2018 to 2030 (USD Billion)
7.2.10. Others
7.2.10.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

8.1. Regional market share analysis, 2021 & 2030
8.2. North America
8.2.1. U.S.
8.2.1.1. U.S. Market estimates and forecast, 2018 - 2030
8.2.2. Canada
8.2.2.1. Canada Market estimates and forecast, 2018 - 2030
8.3. Europe
8.3.1. U.K.
8.3.1.1. U.K. Market estimates and forecast, 2018 - 2030
8.3.2. Germany
8.3.2.1. Germany Market estimates and forecast, 2018 - 2030
8.3.3. France
8.3.3.1. France Market estimates and forecast, 2018 - 2030
8.3.4. Italy
8.3.4.1. Italy Market estimates and forecast, 2018 - 2030
8.3.5. Spain
8.3.5.1. Spain Market estimates and forecast, 2018 - 2030
8.3.6. The Netherlands
8.3.6.1. The Netherlands Market estimates and forecast, 2018 - 2030
8.3.7. Sweden
8.3.7.1. Sweden Market estimates and forecast, 2018 - 2030
8.3.8. Switzerland
8.3.8.1. Switzerland Market estimates and forecast, 2018 - 2030
8.3.9. Russia
8.3.9.1. Russia Market estimates and forecast, 2018 - 2030
8.3.10. Belgium
8.3.10.1. Belgium Market estimates and forecast, 2018 - 2030
8.4. Asia Pacific
8.4.1. Japan
8.4.1.1. Japan Market estimates and forecast, 2018 - 2030
8.4.2. China
8.4.2.1. China Market estimates and forecast, 2018 - 2030
8.4.3. India
8.4.3.1. India Market estimates and forecast, 2018 - 2030
8.4.4. Australia
8.4.4.1. Australia Market estimates and forecast, 2018 - 2030
8.4.5. South Korea
8.4.5.1. South Korea Market estimates and forecast, 2018 - 2030
8.4.6. Thailand
8.4.6.1. Thailand Market estimates and forecast, 2018 - 2030
8.4.7. Malaysia
8.4.7.1. Malaysia Market estimates and forecast, 2018 - 2030
8.4.8. New Zealand
8.4.8.1. New Zealand Market estimates and forecast, 2018 - 2030
8.4.9. Philippines
8.4.9.1. Philippines Market estimates and forecast, 2018 - 2030
8.4.10. Singapore
8.4.10.1. Singapore Market estimates and forecast, 2018 - 2030
8.5. Latin America
8.5.1. Brazil
8.5.1.1. Brazil Market estimates and forecast, 2018 - 2030
8.5.2. Mexico
8.5.2.1. Mexico Market estimates and forecast, 2018 - 2030
8.5.3. Argentina
8.5.3.1. Argentina Market estimates and forecast, 2018 - 2030
8.5.4. Colombia;
8.5.4.1. Colombia Market estimates and forecast, 2018 - 2030
8.5.5. Chile
8.5.5.1. Chile Market estimates and forecast, 2018 - 2030
8.6. MEA
8.6.1. South Africa
8.6.1.1. South Africa Market estimates and forecast, 2018 - 2030
8.6.2. Saudi Arabia
8.6.2.1. Saudi Arabia Market estimates and forecast, 2018 - 2030
8.6.3. UAE
8.6.3.1. UAE Market estimates and forecast, 2018 - 2030
8.6.4. Israel
8.6.4.1. Israel Market estimates and forecast, 2018 - 2030
8.6.5. Egypt
8.6.5.1. Egypt Market estimates and forecast, 2018 - 2030

9.1. Recent Developments & Impact Analysis, By Key Market Participant
9.2. Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
9.3. Participant Categorization
9.3.1. Innovators
9.3.1.1. Recipharm AB
9.3.1.2. Siegfried Holding AG
9.3.1.3. Aurobindo Pharma
9.4. Vendor Landscape
9.4.1. List of Key Service Providers
9.4.2. Market Differentiators
9.4.3. Generic pharmaceuticals contract manufacturing market Share Analysis

10.1. Company Profiles
10.1.1. Recipharm AB
10.1.1.1. Company overview
10.1.1.2. Financial performance
10.1.1.3. Service benchmarking
10.1.1.4. Strategic initiatives
10.1.2. Siegfried Holding AG
10.1.2.1. Company overview
10.1.2.2. Financial performance
10.1.2.3. Service benchmarking
10.1.2.4. Strategic initiatives
10.1.3. Aurobindo Pharma
10.1.3.1. Company overview
10.1.3.2. Financial performance
10.1.3.3. Service benchmarking
10.1.3.4. Strategic initiatives
10.1.4. Cambrex Corporation
10.1.4.1. Company overview
10.1.4.2. Financial performance
10.1.4.3. Service benchmarking
10.1.4.4. Strategic initiatives
10.1.5. Alcami Corporation, Inc.
10.1.5.1. Company overview
10.1.5.2. Financial performance
10.1.5.3. Service benchmarking
10.1.5.4. Strategic initiatives
10.1.6. Curia Global, Inc.
10.1.6.1. Company overview
10.1.6.2. Financial performance
10.1.6.3. Service benchmarking
10.1.6.4. Strategic initiatives
10.1.7. Catalent, Inc
10.1.7.1. Company overview
10.1.7.2. Financial performance
10.1.7.3. Service benchmarking
10.1.7.4. Strategic initiatives
10.1.8. Acme Generics Pvt Ltd.
10.1.8.1. Company overview
10.1.8.2. Financial performance
10.1.8.3. Service benchmarking
10.1.8.4. Strategic initiatives
10.1.9. Metric Contract Services
10.1.9.1. Company overview
10.1.9.2. Financial performance
10.1.9.3. Service benchmarking
10.1.9.4. Strategic initiatives
10.1.10. Syngene International Limited
10.1.10.1. Company overview
10.1.10.2. Financial performance
10.1.10.3. Service benchmarking
10.1.10.4. Strategic initiatives
10.1.11. Pfizer CentreOne;
10.1.11.1. Company overview
10.1.11.2. Financial performance
10.1.11.3. Service benchmarking
10.1.11.4. Strategic initiatives

Table 1 List of secondary sources
Table 2 List of Abbreviations

Fig 1 Market research process
Fig 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Volume Price Analysis
Fig. 10 Generic pharmaceuticals contract manufacturing market snapshot (2021)
Fig. 11 Generic pharmaceuticals contract manufacturing market segmentation
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Porter’s five forces analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 Generic pharmaceuticals contract manufacturing market drug type outlook: Segment dashboard
Fig. 18 Generic pharmaceuticals contract manufacturing market: Drug type movement analysis
Fig. 19 Branded Generics market (USD Billion)
Fig. 20 Unbranded Generics market (USD Billion)
Fig. 21 Generic pharmaceuticals contract manufacturing market product outlook: Segment dashboard
Fig. 22 Generic pharmaceuticals contract manufacturing market: Product movement analysis
Fig. 23 API market (USD Billion)
Fig. 24 Drug Product market (USD Billion)
Fig. 25 Generic pharmaceuticals contract manufacturing market route of adminsitration outlook: Segment dashboard
Fig. 26 Generic pharmaceuticals contract manufacturing market: Route of adminsitrationmovement analysis
Fig. 27 Oral market (USD Billion)
Fig. 28 Topical market (USD Billion)
Fig. 29 Parentral market (USD Billion)
Fig. 30 Others market (USD Billion)
Fig. 31 Generic pharmaceuticals contract manufacturing market application outlook: Segment dashboard
Fig. 32 Generic pharmaceuticals contract manufacturing market: Application movement analysis
Fig. 33 Oncology market (USD Billion)
Fig. 34 Immunology market (USD Billion)
Fig. 35 Antidiabetic market (USD Billion)
Fig. 36 Neurology market (USD Billion)
Fig. 37 Anticoagulants market (USD Billion)
Fig. 38 Cardiovascular market (USD Billion)
Fig. 39 Respiratory market (USD Billion)
Fig. 40 Pain market (USD Billion)
Fig. 41 HIV antivirals market (USD Billion)
Fig. 42 Others market (USD Billion)
Fig. 43 Regional market: Key takeaways
Fig. 44 Regional outlook, 2021 & 2030
Fig. 45 North America market, 2018 - 2030 (USD Billion)
Fig. 46 U.S. market, 2018 - 2030 (USD Billion)
Fig. 47 Canada Market, 2018 -2030 (USD Billion)
Fig. 48 Europe Market, 2018 -2030 (USD Billion)
Fig. 49 U.K. Market, 2018 -2030 (USD Billion)
Fig. 50 Germany Market, 2018 -2030 (USD Billion)
Fig. 51 France Market, 2018 -2030 (USD Billion)
Fig. 52 Italy Market, 2018 -2030 (USD Billion)
Fig. 53 SpainMarket, 2018 -2030 (USD Billion)
Fig. 54 The Netherlands Market, 2018 -2030 (USD Billion)
Fig. 55 Switzerland Market, 2018 -2030 (USD Billion)
Fig. 56 Sweden Market, By Service, 2018 -2030 (USD Billion)
Fig. 57 Asia Pacific market, 2018 - 2030 (USD Billion)
Fig. 58 China market, 2018 - 2030 (USD Billion)
Fig. 59 India market, 2018 - 2030 (USD Billion)
Fig. 60 Japan market, 2018 - 2030 (USD Billion)
Fig. 61 Australia market, 2018 - 2030 (USD Billion)
Fig. 62 Malaysia market, 2018 - 2030 (USD Billion)
Fig. 63 Indonesia market, 2018 - 2030 (USD Billion)
Fig. 64 Taiwan market, 2018 - 2030 (USD Billion)
Fig. 65 Thailand market, 2018 - 2030 (USD Billion)
Fig. 66 Singapore market, 2018 - 2030 (USD Billion)
Fig. 67 South Korea market, 2018 - 2030 (USD Billion)
Fig. 68 Latin America market, 2018 - 2030 (USD Billion)
Fig. 69 Brazil market, 2018 - 2030 (USD Billion)
Fig. 70 Mexico market, 2018 - 2030 (USD Billion)
Fig. 71 Argentina market, 2018 - 2030 (USD Billion)
Fig. 72 Colombia market, 2018 - 2030 (USD Billion)
Fig. 73 MEA market, 2018 - 2030 (USD Billion)
Fig. 74 South Africa market, 2018 - 2030 (USD Billion)
Fig. 75 Saudi Arabia market, 2018 - 2030 (USD Billion)
Fig. 76 Israel market, 2018 - 2030 (USD Billion)
Fig. 77 UAE market, 2018 - 2030 (USD Billion)